Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

ClinicalTrials.gov ID: NCT00367835

Public ClinicalTrials.gov record NCT00367835. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Multi-Center, Flexible Dose Study Evaluating the Efficacy and Safety of SPD503 (Guanfacine Hydrochloride) in Children Aged 6-12 With Symptoms of Oppositionality and a Diagnosis of Attention Deficit/Hyperactivity Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjects with ADHD and oppositional symptoms.

Study identification

NCT ID
NCT00367835
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
217 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2006 (Actual)
Primary completion
Jan 4, 2008 (Actual)
Completion
Jan 4, 2008 (Actual)
Last update posted
Jun 14, 2021

2006 – 2008

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
HOPE Research Institute Phoenix Arizona 85050 —
Valley Clinical Research El Centro California 92243 —
Peninsula Research Associates Inc Rolling Hills Estates California 90274 —
Sarkis Clinical Trials Gainesville Florida 32607 —
University of Florida Gainesville Florida 32610 —
Amedica Research Institute, Inc Hialeah Florida 33013 —
CORE Research, Inc Maitland Florida 32751 —
Miami Research Associates Miami Florida 33143 —
Clinical Neuroscience Solutions, Inc Orlando Florida 32806 —
Childrens Developmental Center Winter Park Florida 32792 —
Capstone Clinical Research Libertyville Illinois 60048 —
Vince and Associates Clinical Research Overland Park Kansas 66212 —
Pedia Research Owensboro Kentucky 42301 —
Four Rivers Clinical Research Paducah Kentucky 42003 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
CRI Worldwide, LLC Clementon New Jersey 08021 —
Mount Sinai School of Medicine New York New York 10029 —
University of Rochester, School of Medicine and Dentistry Rochester New York 14618 —
SUNY Upsate Medical University Syracuse New York 13210 —
Piedmont Neuropsychiatry Charlotte North Carolina 28226 —
Duke Child & Family Study Center Durham North Carolina 27705 —
University of Cincinnati Cincinnati Ohio 45267 —
Discovery and Wellness Center for Children Cleveland Ohio 44106 —
BHI Inc Moore Oklahoma 73160 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Oregon Center for Clinical Investigations, Inc Portland Oregon 97210 —
Oregon Center for Clinical Investigations, Inc Salem Oregon 97301 —
CRI Worldwide, LLC Philadelphia Pennsylvania 19149 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Claghorn-Lesem Research Clinic Inc Houston Texas 77008 —
Red Oak Psychiatry Associates, PA Houston Texas 77090 —
NeuroScience, Inc Herndon Virginia 20170 —
Dominion Clinical Research Midlothian Virginia 23112 —
Eastside Therapeutic Resource Kirkland Washington 98033 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00367835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00367835 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →